NCT03190174 2025-02-17Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersSarcoma Oncology Research Center, LLCPhase 1/2 Completed34 enrolled 14 charts
NCT00464620 2018-11-23Trial of Dasatinib in Advanced SarcomasSarcoma Alliance for Research through CollaborationPhase 2 Completed366 enrolled 16 charts